SCANLOAD: The Effect of Limb Loading on Lower Limb Geometry
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04600102 |
|
Recruitment Status :
Recruiting
First Posted : October 23, 2020
Last Update Posted : September 28, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Foot Injuries and Disorders | Device: Structure Sensor |
Two groups of subjects will be recruited for this study. The first group (Group 1) will consist of healthy, able-bodied individuals with no history of lower extremity trauma. The second group (Group 2) will consist of individuals with unilateral, below-knee functional deficits that require an AFO for daily activities (e.g. fracture, muscle and/or nerve injury, ankle arthritis, or peripheral neurologic disease).
We will obtain a brief medical history to identify major medical conditions or prior injuries that could influence limb geometry and lead to reliance on an AFO for Group 2 participants.
A 3D representation of each participant's lower limb geometry will be obtained using a Structure Core scanner (Occipital, Inc.), which uses an infrared structured light projector to construct a 3D image of an object. The scanner is connected to an iPad; to operate the scanner, the user rotates the iPad camera around the desired object. In seconds, the entire geometry is digitally reconstructed. Measurements will be evaluated using digital imaging analysis software (Standard Cyborg, Inc.). The different conditions being tested are full weight bearing, partial weight bearing, and non-weight bearing. The effect of limb loading on multiple measures of limb geometry will be evaluated. Limb measurements will include 1) width of the metatarsal heads, 2) width of the calcaneus, 3) foot length, 4) foot height, 5) arch height, 6) medial-lateral width between ankle malleoli, 7) minimum circumference above the ankle malleoli, 8) maximum calf circumference , 9) medial-lateral width of the knee condyles 10) anterior-posterior width at mid patellar tendon, 11) distance from bottom of foot to tibial tubercle.
| Study Type : | Observational [Patient Registry] |
| Estimated Enrollment : | 60 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Target Follow-Up Duration: | 2 Days |
| Official Title: | SCANLOAD: The Effect of Limb Loading on Lower Limb Geometry |
| Actual Study Start Date : | October 27, 2020 |
| Estimated Primary Completion Date : | May 2022 |
| Estimated Study Completion Date : | May 2022 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
GROUP 1
Healthy able-bodied individuals with no history of lower extremity trauma.
|
Device: Structure Sensor
A 3D representation of each participant's lower limb geometry will be obtained using a Structure Sensor scanner (Occipital, Inc.) which uses an infrared structured light projector to construct a 3D image of an object. The scanner is connected to an iPad; to operate the user rotates the iPad camera around the desired object. In seconds, the entire geometry is digitally reconstructed. |
|
GROUP 2
Individuals with unilateral, below knee functional deficits that require an AFO for daily activities (e.g. fracture, muscle and/or nerve injury, ankle arthritis, or peripheral neurologic disease).
|
Device: Structure Sensor
A 3D representation of each participant's lower limb geometry will be obtained using a Structure Sensor scanner (Occipital, Inc.) which uses an infrared structured light projector to construct a 3D image of an object. The scanner is connected to an iPad; to operate the user rotates the iPad camera around the desired object. In seconds, the entire geometry is digitally reconstructed. |
- Width of the metatarsal heads [ Time Frame: Less than 2 days ]Distance from the medial aspect of the first metatarsal head to the lateral aspect of the fifth metatarsal head.
- Width of the calcaneus [ Time Frame: Less than 2 days ]Distance from the medial aspect of calcaneus parallel to lateral aspect of calcaneus.
- Foot length [ Time Frame: Less than 2 days ]Distance from the most posterior aspect of calcaneus to the most anterior toe (1st or 2nd).
- Foot height [ Time Frame: Less than 2 days ]Distance from the most superior point on the foot distal to the tibialis anterior insertion.
- Arch height [ Time Frame: Less than 2 days ]Dorsum height at 50% foot length.
- Medial-lateral ankle malleoli width [ Time Frame: Less than 2 days ]Distance from the lateral malleolus to the medial malleolus.
- Minimum ankle circumference [ Time Frame: Less than 2 days ]Minimum ankle circumference above the ankle malleoli. Must be less than 10 cm proximal to the ankle malleoli.
- Maximum calf circumference [ Time Frame: Less than 2 days ]Maximum calf circumference greater that 5 cm distal to the knee condyles.
- Width of the knee condyles [ Time Frame: Less than 2 days ]Distance from the medial condyle to the lateral condyle.
- Anterior-posterior width at patella [ Time Frame: Less than 2 days ]Distance from mid patellar tendon to a parallel point most posterior on the back of the knee.
- Tibial tubercle height [ Time Frame: Less than 2 days ]Distance from the floor to tibial tubercle.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
GROUP 1
Patient Inclusion criteria
- Ages: 18-75
- Healthy individuals without a current complaint of lower extremity pain, spine pain, active infections or medical or neuromusculoskeletal disorders that have limited participation in work or exercise in the last 6 months
- Ability to perform a full squat without pain
- Able to read and write in English and provide written informed consent
Patient Exclusion criteria
- Diagnosed moderate or severe brain injury
- Diagnosis of a physical or psychological condition that would preclude testing (e.g. cardiac condition, clotting disorder, pulmonary condition)
- Current complaint of pain or numbness in the spine
- Uncorrected visual or hearing impairments that limit the ability to understand or comply with instructions given during testing
- Require an assistive device
- Open/unhealed wounds on lower extremity.
- Body mass index (BMI) above 35
GROUP 2
Patient Inclusion criteria
- Ages: 18-75
- Daily AFO use to address unilateral below knee functional deficits (e.g. fracture, muscle and/or nerve injury, ankle arthritis, or peripheral neurologic disease)
- Ability to stand independently without use of an assistive device (Cane, crutch, etc)
- Ability to safely bear full body weight on affected limb without use of an AFO or other protection
- Able to read and write in English and provide written informed consent
Patient Exclusion criteria
- Use of an AFO that crosses the knee (includes Knee brace or similar)
- Open/unhealed wounds on lower extremity
- Uncorrected visual or hearing impairments that limit the ability to understand or comply with instructions given during testing
- Body mass index (BMI) above 35
- Diagnoses of a moderate to severe brain injury
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04600102
| Contact: Jason M Wilken, PT, PhD | 319-335-6857 | jason-wilken@uiowa.edu |
| United States, Iowa | |
| University of Iowa | Recruiting |
| Iowa City, Iowa, United States, 52242 | |
| Contact: Jason M Wilken, PT, PhD 319-335-6857 jason-wilken@uiowa.edu | |
| Contact: Molly Pacha, MS, ATC, LAT 319-290-7596 molly-pacha@uiowa.edu | |
| Sub-Investigator: Jeff Palmer, CPO, LPO | |
| Sub-Investigator: Molly Pacha, MS, ATC, LAT | |
| Sub-Investigator: Natalie Glass, PhD | |
| Principal Investigator: | Jason M Wilken, PT, PhD | University of Iowa |
| Responsible Party: | Jason Wilken, Principal Investigator, University of Iowa |
| ClinicalTrials.gov Identifier: | NCT04600102 |
| Other Study ID Numbers: |
IRB# 201907735 |
| First Posted: | October 23, 2020 Key Record Dates |
| Last Update Posted: | September 28, 2021 |
| Last Verified: | September 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | Yes |
| Product Manufactured in and Exported from the U.S.: | No |
|
Ankle Foot Orthosis Adult 3D Limb Scanning Limb Geometry Limb Loading |
|
Foot Injuries Leg Injuries Wounds and Injuries |

